Allergan Plc

AGN
The New York Stock Exchange
Company profile


Market capMega (62.47B)
Company CEOBrenton L. Saunders

Allergan Plc

AGN
The New York Stock Exchange
Company profile


Market capMega (62.47B)
Company CEOBrenton L. Saunders
$190.3Price snapshot
$2.96Annual dividend
1.56 %Dividend yield
UnknownDividend growth (3y)
N/ATraling P/E
-Forward P/E
-Payout ratio
-EPS

AGN DIVIDEND PAYOUT HISTORY

Loading...

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States.

The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

PRICE HISTORY Allergan Plc

Loading price stock history...

Allergan Plc latest news

Loading latest news...